Table 3 Validation cohort 2: clinical characteristics of patients for western blot experiment
Patients | Number (%) | |
|---|---|---|
Number | 74 | |
Age(y), mean(range) | 60.7 (24–87) | |
Histology | Serous | 48 (64.9) |
Non Serous | 26 (35.1) | |
Stage | I | 11 (16.4) |
II | 5 (7.5) | |
III | 42 (62.7) | |
IV | 9 (13.4) | |
Grade | 1 | 9 (16.9) |
2 | 5 (9.4) | |
3 | 39 (73.6) | |
Chemotherapy | Neo-adjuvant | 34 (46) |
Adjuvant | 25 (34) | |
Surgery | Laparotomy | 30 (46) |
Laparoscopy | 2 (3) | |
Robotic | 33 (51) | |
Residual disease | 8 (10.8) | |
Response | Responsive | 33 (75) |
Resistant | 11 (25) | |
Recurrence | Number | 27 (36.5) |
Mean time (range) | 9.6 months (3–29) | |
Deceased | Number | 21 (31.3) |
Mean time (range) | 26.5 months (4–88) | |
Follow-up | Mean time (range) | 31.4 months (7–107) |